Pfizer and BionTech will deliver through the international vaccine-sharing facility COVAX some of the 2 billion COVID-19 vaccine doses it announced on Friday as new supplies for low- and middle-income countries.
The doses will be allocated “through bilateral agreements, agreements with supranational organizations as well as our partnership with COVAX,” a Pfizer spokesman said.
The daily email you need for
's top news stories.
Earlier on Friday a BioNTech spokeswoman said: “We are currently still evaluating this.”